Tybourne Capital Management (Hk) LTD Forte Biosciences, Inc. Call Options Transaction History
Tybourne Capital Management (Hk) LTD
- $398 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FBRX
# of Institutions
30Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY3.27MShares$15 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$13.7 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$9.35 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$8.46 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.81MShares$8.33 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $93.6M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.